CClinicalTrials.gg
CompletedNCT01463787Updated Apr 10, 2013

Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial

A Phase 4 interventional study of microsurgical varicocelectomy in inguinal approach and microsurgical varicocelectomy in subinguinal approach in Varicocele, sponsored by Feng Pan. Completed at 1 site in China. Open to male participants aged 20 Years to 46 Years. Per ClinicalTrials.gov, last updated 2013-04-10.

Sponsored by Feng Pan · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
20 Years to 46 Years
Sex
Male
01

Study summary

Varicocele is the most common surgical disease which could lead to male infertility. It is found in approximately 15% adult males, and in about 40% infertile males. And the incidence is up to 80% in secondary infertility. In the past, there was continuous controversy over whether a varicocele repair could improve fertility. But at present, researches are coming to a consensus on the indication of varicocelectomy. Several researches manifest that the microsurgery of varicocele could have the effect of the highest spontaneous pregnancy and lowest complications rate after surgery. Microsurgical varicocelectomy includes two approaches, inguinal and subinguinal. Each one has its advantages and disadvantages. There are few studies which make direct comparison between the two methods in microsurgical varicocelectomy, especially in China. Operators have made decisions on the basis of their own experience and skills. In this study, the investigators compare the postoperative spontaneous pregnancy and complications rates in two approaches in microsurgical varicocelectomy for Chinese infertile men in their hospital.

Read the detailed description

Outcome Measures

Before surgery, all patients were diagnosed by physical examination and testified by color Doppler ultrasound. And one trained nurse documented the patients' age, left unilateral or bilateral and the grade of varicocele, and the grade of the more serious side was noted when handled with bilateral ones. During surgery, the duration of surgery was documented. After surgery, a Visual Analogue Scale (VAS) was used to assess the introperative pain after anesthesia recovery and the amount of postoperative pain one month postoperatively by another trained nurse. And the patients whose pain scores > 3 and/or who claimed pain were prescribed with ibuprofen sustained-release capsules (China SmithKline Pharmaceutical Company, Tianjing, China) (0.3g) (ISRC) every 12h on the surgical day (since 2h postoperatively) and only if necessary on the following days (no patient claimed that he had gastrointestinal ulcer history or allergic history of relative drug). Parents were told to write down on a provided form how many times they gave medicine postoperatively. Patients were followed with visits 1 month, 3, 6 and 12 months after surgery, and were encouraged to visit the clinic anytime when they had any complaint in this period. The semen analyses were conducted in the 3, 6 and 12 months in the follow-up. The recurrence or hydrocele formation was testified by color Doppler ultrasound (with/without detected by physical examination) by the same doctor who did the preoperative examination. And this doctor and two nurses mentioned above were all unaware of the patients' groups.

02

Conditions studied

  • Varicocele

Browse trials for

Keywords

  • Infertility
  • varicocelectomy
  • microsurgery
  • Chinese men
  • pregnancy rate
03

Who can participate

Ages eligible
20 Years to 46 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Primary infertility (more than 1 year)
  2. Serum hormone was normal (FSH, LH, T and PRL)
  3. Semen analysis which was taken within 3-7 days of abstinence was abnormal for at least twice, and at least 1 month apart (the value of sperm density was less than 20 million per ml, and/or sperm motility a+b was less than 50%, according to the 4th WHO criteria)
  4. All varicocele was diagnosed by physical examination and testified by color Doppler ultrasound
  5. Patients' spouse was healthy in reproduction or had some curable generational diseases

Exclusion criteria

Exclusion Criteria:

  1. Secondary infertility
  2. Men with subclinical varicocele or normal semen analyses
  3. Having some other surgical diseases, such as genital tract infection or deformity
  4. Having some congenital diseases, such as Klinefelter and Y chromosome deficiency
  5. Having some endocrine diseases, such as Kallmann, abnormality in pituitary gland, hyperthyroidism, hypercorticoidism, and so on
  6. Patients' spouse had some diseases that made them unable to carry out spontaneous pregnancy, such as tubal obstruction or ovulatory failure.
04

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    inguinal group

    Procedure: microsurgical varicocelectomy in inguinal approach

  • Active comparator
    sub-inguinal group

    Procedure: microsurgical varicocelectomy in subinguinal approach

Interventions

  • Proceduremicrosurgical varicocelectomy in inguinal approach

    In inguinal approach, the incision, which was about 3cm, was made two fingers up the pubic symphysis, from external inguinal rings parallel to the inguinal ligament.

  • Proceduremicrosurgical varicocelectomy in subinguinal approach

    In subinguinal approach, the incision was about 3 cm horizontal and 1 cm below the external inguinal ring.

05

What researchers measure

Primary outcomes

  1. pregnancy

    Postoperative spontaneous pregnancy is considered to be the best indicator to assess fertility status.

    Time frame: within the 12-24 months postoperative period

06

Study locations

1 site
  • Nanjing Maternity and Child Healthcare Hospital Affiliated to Nanjing Medical University
    Nanjing, Jiangsu 210004, China
07

Registry details

Key details

Study ID
NCT01463787
Lead sponsor
Feng Pan
Responsible party
Feng Pan (Clinical Attending Doctor, Nanjing Medical University) — Sponsor-investigator
First posted
Nov 2, 2011
Start date
Jan 2009
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Apr 10, 2013

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion